Oral EN - Search Results

1

Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center.

Ak N, Toker A, Kara M, Özkan B, Ülker M, Kaba E, Yeğen G, Karaman Ş, Dağoğlu N, Kaytan Sağlam E, Oral EN, Kızır A, Bayraktar S, Dişçi R, Ferhatoğlu F, Aydın E, Vatansever S, Eralp Y, Aydıner A. Ak N, et al. Among authors: oral en. Turk Gogus Kalp Damar Cerrahisi Derg. 2021 Oct 20;29(4):487-495. doi: 10.5606/tgkdc.dergisi.2021.20529. eCollection 2021 Oct. Turk Gogus Kalp Damar Cerrahisi Derg. 2021. PMID: 35096446 Free PMC article.

2

A phase II trial, feasibility of combination of daily cisplatinum and accelerated radiotherapy via concomitant boost in stage III non-small cell lung cancer.

Sarihan S, Darendeliler E, Kizir A, Tuncel N, Oral EN, Karadeniz A, Bilge N. Sarihan S, et al. Among authors: oral en. Lung Cancer. 1998 Apr;20(1):37-46. doi: 10.1016/s0169-5002(98)00003-8. Lung Cancer. 1998. PMID: 9699186 Clinical Trial.

3

Preliminary analysis of a phase II study of Paclitaxel and CHART in locally advanced non-small cell lung cancer.

Oral EN, Bavbek S, Kizir A, Tenececi N, Yöney A, Kaytan E, Topuz E. Oral EN, et al. Lung Cancer. 1999 Sep;25(3):191-8. doi: 10.1016/s0169-5002(99)00068-9. Lung Cancer. 1999. PMID: 10512130 Clinical Trial.

4

Response evaluation of bone metastases in breast cancer: value of magnetic resonance imaging.

Saip P, Tenekeci N, Aydiner A, Dinçer M, Inanç S, Demir C, Oral EN, Topuz E. Saip P, et al. Among authors: oral en. Cancer Invest. 1999;17(8):575-80. doi: 10.3109/07357909909032842. Cancer Invest. 1999. PMID: 10592764 Clinical Trial.

5

Resectable thymoma: treatment outcome and prognostic factors in the late adolescent and adult age group.

Eralp Y, Aydiner A, Kizir A, Kaytan E, Oral EN, Topuz E. Eralp Y, et al. Among authors: oral en. Cancer Invest. 2003;21(5):737-43. doi: 10.1081/cnv-120023772. Cancer Invest. 2003. PMID: 14628432

6

Induction and concurrent chemotherapy with concomitant boost radiotherapy in non-small cell lung cancer.

Oral EN, Aydiner A, Eralp Y, Topuz E. Oral EN, et al. Med Oncol. 2005;22(4):367-74. doi: 10.1385/MO:22:4:367. Med Oncol. 2005. PMID: 16260854 Clinical Trial.

7

The results of concomitant and sequential chemoradiotherapy with cisplatin and etoposide in patients with locally advanced non-small cell lung cancer.

Saynak M, Aksu G, Fayda M, Kaytan E, Oral E, Gurocak S, Kizir A, Karadeniz A. Saynak M, et al. J BUON. 2005 Apr-Jun;10(2):213-8. J BUON. 2005. PMID: 17343331

8

Treatment outcome and prognostic factors in non-metastatic esophageal carcinoma.

Saglam EK, Kilciksiz S, Ozseker N, Karadeniz A, Oral EN, Kizir A. Saglam EK, et al. Among authors: oral en. Saudi Med J. 2007 Jul;28(7):1086-90. Saudi Med J. 2007. PMID: 17603717

9

Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer.

Sen F, Saglam EK, Toker A, Dilege S, Kizir A, Oral EN, Saip P, Sakallioglu B, Topuz E, Aydiner A. Sen F, et al. Among authors: oral en. Cancer Chemother Pharmacol. 2011 Dec;68(6):1497-505. doi: 10.1007/s00280-011-1642-8. Epub 2011 Apr 17. Cancer Chemother Pharmacol. 2011. PMID: 21499895

10

Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: a phase II study.

Aydiner A, Sen F, Saglam EK, Oral EN, Eralp Y, Tas F, Toker A, Dilege S. Aydiner A, et al. Among authors: oral en. Clin Lung Cancer. 2011 Sep;12(5):286-92. doi: 10.1016/j.cllc.2011.03.030. Epub 2011 May 8. Clin Lung Cancer. 2011. PMID: 21729649 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page